ADAM19 expression in human nephrogenesis and renal disease: Associations with clinical and structural deterioration

作者：Melenhorst W B W H^*; van den Heuvel M C; Timmer A; Huitema S; Bulthuis M; Timens W; van Goor H

来源：Kidney International, 2006, 70(7): 1269-1278.

DOI：10.1038/sj.ki.5001753

• ADAM19
• pathology
• pathophysiology of renal disease and progression
• renal biopsy
• renal pathology
• renal transplantation

ADAM19, an enzyme from the ADAM (a disintegrin and metalloproteinase) family, is involved in various cell-cell and cell-matrix interactions. It can cleave epidermal growth factor (EGF)-like growth factors, such as heparin-binding (HB)-EGF and neuregulin (NRG), from the cell membrane. ADAM-mediated EGF receptor activation is crucial in the development of renal pathology. Based on these data, we studied ADAM19 in human nephrogenesis and renal disease. We collected 20 fetal kidneys and 56 biopsies from patients with various renal diseases. The unaffected part of kidneys from eight patients with renal cell carcinoma served as control. RNA in situ hybridization revealed widespread ADAM19 mRNA expression in the nephrogenic zone of human fetal kidneys. Normal human kidneys showed constitutive ADAM19 expression in distal tubules and endothelial cells, whereas proximal tubules were negative. In renal disease, ADAM19 was de novo expressed in proximal tubules and glomerular mesangium and upregulated in distal tubules and endothelial cells. ADAM19 colocalized with tubular and interstitial NRG, however, not with HB-EGF. Independent of renal disorder, mesangial ADAM19 expression was associated with glomerular damage as assessed by mesangial matrix expansion, focal glomerulosclerosis, and glomerular macrophage influx (all P < 0.001). ADAM19 in proximal tubules and in peritubular capillaries was associated with interstitial fibrosis (P < 0.05). Finally, increasing tubular ADAM19 was associated with declining renal P < 0.05). The abundant ADAM19 expression during nephrogenesis points to a role in growth promotion and regulation. The high ADAM19 expression in renal disease suggests involvement in profibrotic and proinflammatory processes leading to renal deterioration.

• 出版日期2006-10